| scholarly article | Q13442814 |
| P50 | author | Matteo Gulino | Q58638233 |
| Valentina Silvestri | Q64821309 | ||
| Stefania Tommasi | Q37843386 | ||
| P2093 | author name string | L Ottini | |
| R Pinto | |||
| M Falchetti | |||
| P Frati | |||
| P Rizzolo | |||
| K Danza | |||
| P2860 | cites work | Identification of differentially expressed microRNAs in human male breast cancer | Q21261330 |
| The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors | Q22010018 | ||
| PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene | Q24615080 | ||
| Multidisciplinary meeting on male breast cancer: summary and research recommendations | Q24631800 | ||
| Genome-wide association study identifies novel breast cancer susceptibility loci | Q24645441 | ||
| Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers | Q24655824 | ||
| Breast cancer epigenetics: from DNA methylation to microRNAs | Q27694164 | ||
| Cancer statistics, 2010 | Q27860525 | ||
| Tumour invasion and metastasis initiated by microRNA-10b in breast cancer | Q28131829 | ||
| Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations | Q28215462 | ||
| Causes and consequences of microRNA dysregulation in cancer | Q28258994 | ||
| Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations | Q28265304 | ||
| Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene | Q28280022 | ||
| Novel genetic variants in microRNA genes and familial breast cancer | Q28302410 | ||
| Rare mutations in XRCC2 increase the risk of breast cancer | Q28730692 | ||
| Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk | Q29417050 | ||
| Cancer epigenomics: DNA methylomes and histone-modification maps | Q29615524 | ||
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium | Q29619206 | ||
| The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews | Q29619407 | ||
| Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central Italy | Q33296526 | ||
| Principles of microRNA involvement in human cancers | Q33579255 | ||
| Exploring the link between germline and somatic genetic alterations in breast carcinogenesis | Q33761201 | ||
| Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer | Q33810128 | ||
| microRNA and cancer | Q33954625 | ||
| Multiple loci with different cancer specificities within the 8q24 gene desert | Q33988405 | ||
| Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men | Q34031201 | ||
| An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer | Q34085123 | ||
| A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). | Q34085748 | ||
| Genome-wide association study identifies five new breast cancer susceptibility loci | Q34114293 | ||
| Genetic heterogeneity of 8q24 region in susceptibility to cancer. | Q54494898 | ||
| A recurrent mutation in PALB2 in Finnish cancer families. | Q55043120 | ||
| Male breast cancer | Q57140621 | ||
| A common coding variant in CASP8 is associated with breast cancer risk | Q57250674 | ||
| Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer | Q57251792 | ||
| The emerging landscape of breast cancer susceptibility | Q57272203 | ||
| Are PALB2 mutations associated with increased risk of male breast cancer? | Q57305998 | ||
| Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy | Q57419705 | ||
| PALB2 mutations in male breast cancer: a population-based study in Central Italy | Q57419720 | ||
| BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy | Q57419722 | ||
| Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy | Q57419725 | ||
| BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases | Q57419733 | ||
| Fanconi anemia and breast cancer susceptibility meet again | Q57499930 | ||
| A Range of Cancers Is Associated with the rs6983267 Marker on Chromosome 8 | Q57666866 | ||
| Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families | Q57882113 | ||
| The role of disease characteristics in the ethical debate on personal genome testing | Q34133195 | ||
| Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States | Q34687498 | ||
| MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression | Q35005168 | ||
| Mutation screening of RAD51C in male breast cancer patients. | Q35029569 | ||
| Personalized medicine: new genomics, old lessons | Q35082635 | ||
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) | Q35737888 | ||
| The genetic epidemiology of breast cancer genes | Q35959353 | ||
| Interactions of intergenic microRNAs with mRNAs of genes involved in carcinogenesis | Q36100480 | ||
| A review of the diagnosis and management of male breast cancer | Q36217973 | ||
| An international comparison of male and female breast cancer incidence rates | Q36557024 | ||
| Genome-wide association analysis identifies three new breast cancer susceptibility loci | Q36842233 | ||
| Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification | Q36924432 | ||
| Genetic susceptibility loci for breast cancer by estrogen receptor status | Q37156413 | ||
| Hereditary breast cancer: from molecular pathology to tailored therapies | Q37235804 | ||
| MicroRNA expression profiling of male breast cancer | Q37360228 | ||
| Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. | Q37369631 | ||
| MicroRNA function in cancer: oncogene or a tumor suppressor? | Q37655612 | ||
| Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation | Q37709882 | ||
| Architecture of inherited susceptibility to common cancer | Q37736259 | ||
| Pathology of hereditary breast cancer | Q37740949 | ||
| The epigenetics of breast cancer | Q37772356 | ||
| Intracellular and extracellular microRNAs in breast cancer | Q37808080 | ||
| Phenotype-genotype correlation in familial breast cancer | Q37852615 | ||
| The inheritance of epigenetic defects | Q39671673 | ||
| Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium | Q40282176 | ||
| Genetic susceptibility to breast cancer | Q41130542 | ||
| Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations | Q41194578 | ||
| CHEK2 1100delC is not a risk factor for male breast cancer population | Q43689349 | ||
| The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy. | Q44955073 | ||
| Different methylation and microRNA expression pattern in male and female familial breast cancer | Q44993991 | ||
| Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers | Q46776482 | ||
| Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals | Q46796026 | ||
| Male cancer: a qualitative study of male breast cancer. | Q47203523 | ||
| miRNA_Targets: a database for miRNA target predictions in coding and non-coding regions of mRNAs. | Q48046645 | ||
| Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. | Q50547706 | ||
| Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy. | Q51527655 | ||
| RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development. | Q53190494 | ||
| P921 | main subject | male breast cancer | Q6742919 |
| medical ethics | Q237151 | ||
| research ethics | Q1132684 | ||
| P304 | page(s) | viii75-viii82 | |
| P577 | publication date | 2013-11-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Male breast cancer: genetics, epigenetics, and ethical aspects | |
| P478 | volume | 24 Suppl 8 |
| Q38370881 | ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS. |
| Q51102259 | Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy. |
| Q33856007 | Breast Cancer: Exploring the Facts and Holistic Needs during and beyond Treatment |
| Q37106641 | Cancer of unknown primary ultimately diagnosed as male breast cancer: A rare case report |
| Q48112811 | Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer. |
| Q42378369 | Clinicopathological characteristics and survival outcomes of male breast cancer according to race: A SEER population-based study |
| Q60046965 | Contribution of Variants to Male Breast Cancer Risk: Results From a Multicenter Study in Italy |
| Q92125098 | Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk |
| Q28245725 | Gynaecomastia--pathophysiology, diagnosis and treatment |
| Q60935866 | Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report |
| Q40072682 | Increased risk of arterial thromboembolism in older men with breast cancer |
| Q37621955 | Male Breast Cancer Incidence and Mortality Risk in the Japanese Atomic Bomb Survivors - Differences in Excess Relative and Absolute Risk from Female Breast Cancer |
| Q57817703 | Male accessory breast cancer on the abdominal wall: a case report and literature review |
| Q31043651 | Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. |
| Q57105520 | Male breast cancer: a disease distinct from female breast cancer |
| Q64049818 | Male breast cancer: a rare disease that might uncover underlying pathways of breast cancer |
| Q55075271 | Marital Status and Survival of Patients with Hormone Receptor-Positive Male Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study. |
| Q47153761 | Metastatic Breast Carcinoma to the Superior Oblique in a Male |
| Q90413979 | Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management |
| Q61809707 | Nomogram Predicting Cause-Specific Mortality in Nonmetastatic Male Breast Cancer: A Competing Risk Analysis |
| Q40643761 | Population Landscape of Familial Cancer |
| Q36356727 | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores |
| Q37687527 | Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers. |
| Q36689124 | TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer |
| Q38676450 | The Epidemiology of Male Breast Cancer |
| Q57105429 | The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications |
| Q40573572 | Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene. |
Search more.